Tumor marker CA 11-19 as a new serum blood test for monitoring colorectal cancer.

Authors

null

John J. Costanzi

Lone Star Oncology Consultants, Austin, TX

John J. Costanzi , Tommye Ann Jordan , Lisa Jensen-long

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Prevention, Diagnosis, and Screening

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 536)

DOI

10.1200/jco.2016.34.4_suppl.536

Abstract #

536

Poster Bd #

C5

Abstract Disclosures

Similar Posters

Poster

2016 Gastrointestinal Cancers Symposium

A novel 2-gene blood test for colorectal cancer recurrence.

A novel 2-gene blood test for colorectal cancer recurrence.

First Author: Susanne Kartin Pedersen

Poster

2016 Gastrointestinal Cancers Symposium

Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennaryN-glycan as a novel tumor marker for colorectal cancer.

Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennaryN-glycan as a novel tumor marker for colorectal cancer.

First Author: Eiji Shinozaki

Poster

2014 ASCO Annual Meeting

CA 11-19 as a tumor marker for the diagnosis of colorectal cancer.

CA 11-19 as a tumor marker for the diagnosis of colorectal cancer.

First Author: Bergein F Overholt